Inventor · disambiguated record
Denis G. Kay
Also filed as: KAY DENIS G · KAY DENIS GEORGE
3 granted patents·12 pending applications·2 citations·filing 1999–2025
52Inventor score
Files withNEURODYN INC6KAY DENIS G4ALPHA COGNITION INC3INST RECH S CLINIQUES DE MONTR1SHAW CHRISTOPHER ARIEL1
Top patents by PatentIndex Score
15 records- 0175US12208167B1Coated tablets for pH-dependent release of benzgalantamineALPHA COGNITION INC·Filed 2024·Granted Jan 28, 2025·1 cites·25 claims
- 0267US2022265770A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2022·Application pending·0 cites
- 0358US2021008163A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2020·Application pending·0 cites
- 0455US2019388507A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2019·Application pending·0 cites
- 0554US2010324127A1Treating neurodegenerative diseases with progranulinKAY DENIS G·Filed 2009·Application pending·0 cites
- 0653US9573972B2Nurotoxic sterol glycosidesSHAW CHRISTOPHER ARIEL·Filed 2009·Granted Feb 21, 2017·0 cites·8 claims
- 0753US2020390857A1Method for increasing neprilysin expression and activityKAY DENIS G·Filed 2020·Application pending·0 cites
- 0852US2019060401A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2018·Application pending·0 cites
- 0952US2025092105A1Granulin/epithelin modules and combinations thereof to treat neurodegenerative diseaseALPHA COGNITION INC·Filed 2022·Application pending·0 cites
- 1050US2018064788A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2017·Application pending·0 cites
- 1147US2017128531A1Treating neurodegenerative diseases with progranulinNEURODYN INC·Filed 2016·Application pending·0 cites
- 1244US2019282662A1Method for increasing neprilysin expression and activityKAY DENIS G·Filed 2019·Application pending·0 cites
- 1338US2015352185A1Method for increasing neprilysin expression and activityKAY DENIS G·Filed 2011·Application pending·0 cites
- 1431US2025248941A1Coated tablets for ph-dependent release of benzgalantamineALPHA COGNITION INC·Filed 2025·Application pending·0 cites
- 1520US6184436B1Transgenic mice expressing HIV-1 in immune cellsINST RECH S CLINIQUES DE MONTR·Filed 1999·Granted Feb 6, 2001·1 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Denis G. Kay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →